Clinical Trials Browser

Phase 1/2 × OTHER × capivasertib × Clear all

Leukemia, Lymphoma

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

472 enrolled

Tumor-Agnostic

Neoplasms

NCT07175415 2025-09-16

HEM-iSMART E

Phase 1/2 Not yet recruiting

42 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02121639 2022-05-05

ProCAID

Phase 1/2 Completed

160 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

CAVALRY

ESMART

HEM-iSMART E

ProCAID